BIO 2026台康秀雙軌策略，生物相似藥與CDMO拓展美國市場 

林靜雯資深副總暨業務長分享台康生技如何透過 CDMO 與生物相似藥雙引擎策略，掌握全球生物製藥供應鏈重組所帶來的新契機。

劉董事長談生物相似藥、CDMO發展策略與全球成長藍圖

Connecting with California’s Biopharma Community to Foster Strategic CDMO Partnerships and Innovation

Connecting with Global Bioprocessing Leaders at BioProcess International 2026

Engaging with Biopharma Leaders to Explore Breakthrough Technologies Advancing Human Health and Biologics Innovation.

Strengthening Strategic Global Partnerships Through CPHI Worldwide 2026

Connecting Global Innovation with Taiwan’s Advanced Biopharmaceutical Manufacturing Ecosystem at BioJapan 2026